Close
Home News Page 403

News

This section brings in the latest news and the headlines in the Pharmaceutical industry. Our dedicated news team closely observes the Pharma Industry and keeps you updated of latest developments across the world.

One million signatures needed to call upon World Health Organisation


The 1 Mission 1 Million - Getting to the Heart of Stroke initiative is...

Biomarker predicts response to cancer treatment


VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might...

FDA approves generic versions of blood thinner Plavix


The U.S. Food and Drug Administration approved generic versions of the blood thinning drug...

Amgen’s BiTEĀ® antibody blinatumomab achieved high rate of complete response


Amgen announced updated results from a Phase 2 study that showed treatment with blinatumomab...

In drug-approval race, US FDA ahead of Canada, Europe


The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier...

Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on DiabetesĀ® to China and...


The Bristol-Myers Squibb Foundation today announced the expansion of its Together on DiabetesĀ® initiative...

Serious safety concerns around unlicensed ocular bevacizumab use versus Lucentis


Ā  Recently announced results from two-year CATT (Comparison of Age-related macular degeneration Treatment Trials) adds...

AstraZeneca to acquire Ardea Biosciences for $1 billion


AstraZeneca and Ardea Biosciences, Inc. have entered into a definitive merger agreement, pursuant to which...

Key protein responsible for controlling nerve cell protection


A key protein, which may be activated to protect nerve cells from damage during...

Rosetta wins European patent covering core element of microRNA technology


Rosetta Genomics has won a European patent covering the use of miR-34a in the...